Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome

Journal of Endocrinological Investigation

Volumn 27, Issue 8, 2004, Pages 747-753

  Majnik, J ^a   Szucs N ^a   Patocs A ^a   Toth M ^a   Balogh, K ^a   Varga, I ^a   Glaz E ^a   Racz K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adrenal incidentaloma; Cushing's syndrome; Glucocorticoids; Serum osteocalcin; Serum crosslaps

Indexed keywords

BIOLOGICAL MARKER; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; METYRAPONE; OSTEOCALCIN; TETRACOSACTIDE;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DIET RESTRICTION; DRUG MECHANISM; FEMALE; HORMONE ACTION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNOASSAY; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE;

EID: 10244240632     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347517     Document Type: Article

References (38)

1. Manelli F, Bossoni S, Carpinteri R, et al. Sensitivity of bone remodeling markers in elderly male patients chronically treated with glucocorticoids. J Endocrinol Invest 1999, 22 (Suppl): 79-80.
2. Falcini F, Ermini M, Bagnoli F. Bone turnover is reduced in children with juvenile rheumatoid athritis. J Endocrinol Invest 1998, 21: 31-6.
3. Okabe R, Nakatsuka K, Inaba M, et al. Clinical evaluation of the Elecsys β-Crosslaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 2001, 47: 1410-4.
4. Chiodini I, Carnevale V, Torlontano M, et al. Alteration of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrhoeic patients with Cushing's syndrome. J Clin Endocrinol Metab 1998, 83: 1863-7.
5. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocinol Metab 1991, 72: 382-6.
6. Piovesan A, Terzolo M, Reimondo G, et al. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 1994, 26: 234-7.
7. Rosenquist C, Quist F, Bjarnason N, Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995, 41: 1439-45.
8. Gundberg CM. Biochemical markers of bone formation. Clin Lab Med 2000, 20: 489-501.
9. Rosenquist C, Fledelius C, Christgau S, et al. Serum crosslaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 1998, 44: 2281-9.
10. Morrison NA, Shine J, Fragonas J-C, Verkest V, McMenemy ML, Eisman JA. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989, 246: 1158-61.
11. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996, 81: 3441-7.
12. Weinstein RS, Jilka LR, Parfitt M., Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 1998, 102: 274-82.
13. Godang K, Ueland T, Bollerslev J. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. Eur J Endocrinol 1999, 141: 126-31.
14. Manolagas SC, Weinstein RS. Perspective: new developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14: 1061-6.
15. Chiodini I, Tauchmanová L, Torlontano M, et al. Bone involvement in eugonadal male patients with adrenal incidentaloma and subdinical hypercortisolism. J Clin Endocrinol Metab 2002, 87: 5491-4.
16. Torlontano M, Chiodini I, Pileri M, et al. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 1999, 84: 2381-5.
17. Nielsen HK, Charles P, Mosekilde L. The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 1988, 67: 1025-30.
18. Conti A, Sartorio A, Ferrero S, Ferrario S, Ambrosi B. Modification of biochemical markers of bone and collagen turnover during corticosteroid therapy. J Endocrinol Invest 1996, 19: 127-30.
19. Ardissone P, Rota E, Durelli L, Limone P, Isaia GC. Effects of high doses of corticosteroids on bone metabolism. J Endocrinol Invest 2002, 25: 129-33.
20. Lems WF, Jacobs JWG, van den Brink HR, van Rijn HJM, Bijlsma JWJ. Transient decrease in osteocalcin and markers of type 1 collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis. Br J Rheumatol 1993, 32: 787-9.
21. Lems WF, Gerrits MI, Jacobs JWG, van Vugt RM, van Rijn HJM, Bijlsma JWJ. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 1996, 55: 288-93.
22. Ekenstam E, Stålenheim G, Hällgren R. The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 1988, 37: 141-4.
23. Lamberts SWJ, Huizenga ATM, deLange P, deJong FH, Koper JW. Clinical aspects of glucocorticoid sensitivity. Steroids 1996, 61: 157-60.
24. Vecsei P, Onyechi J, Hornung J, et al. Use of corticosteroid antibodies for the study of corticosteroid biosynthesis in vitro. J Steroid Biochem 1975, 6: 383-7.
25. Conolly TM, Vecsei P. Simple radioimmunoassay of cortisol in diluted samples of human plasma. Clin Chem 1978, 24: 1466-72.
26. Nielsen HK, Laurberg P, Brixen K, Mosekilde L. Relations between variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol (Copenh) 1991, 124: 391-8.
27. Heshmati HM, Riggs BL, Burritt MF, McAlister CA, Wollan PC, Khosla S. Effect of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab 1998, 83: 751-6.
28. Hermus AR, Smals AG, Swinkels LM, et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995, 80: 2859-65.
29. Francucci CM, Pantanetti P, Garrapa GG, Massi F, Arnaldi G, Mantero F. Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol (Oxf) 2002, 57: 587-93.
30. Osella G, Terzolo M, Reimondo G, et al. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 1997, 82: 3303-7.
31. Cortet B, Cortet C, Blanckaert F, et al. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome. Osteoporos Int 2001, 12: 117-23.
32. Sartorio A, Conti A, Ferrero S, et al. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol 1998, 138: 146-52.
33. Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G. Osteocalcin levels in Cushing's disease before and after treatment. Horm Metab Res 1988, 20: 70.
34. Sartorio A, Conti A, Ferrario S, Passini E, Re T, Ambrosi B. Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome. Postgrad Med J 1996, 72: 419-22.
35. Ambrosi B, Peverelli S, Passini E, et al. Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol 1995, 132: 422-8.
36. Osella G, Raimondo G, Peretti P, et al. The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J Clin Endocrinol Metab 2001, 86: 604-7.
37. Bardet S, Rohmer V, De Casson FB, et al. Bone density and biochemical bone markers in patients with adrenal incidentaloma: effect of subdinical hypercortisolism. Rev Med Interne 2002, 23: 508-17.
38. Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000, 85: 1440-8.